Skip to main content
Log in

Disturbance in cerebral spinal fluid sphingolipid content is associated with memory impairment in subjects infected with the human immunodeficiency virus

  • Published:
Journal of NeuroVirology Aims and scope Submit manuscript

Abstract

Despite widespread use of antiretroviral therapies to control replication of the human immunodeficiency virus (HIV), dysfunctions of cognition that are collectively termed HIV-associated neurocognitive disorders (HAND) still occur in approximately 50% of those infected by the virus. Currently there is not a biomarker that can identify HIV-infected people who are at risk for the development of HAND. Previous studies have identified particular sphingolipid species that are dysregulated in HAND, but the neurocognitive correlates of these biochemical findings are not currently understood. To address this question, we compared cerebrospinal fluid (CSF) levels of sphingomyelin, ceramide, and sterol species with performance on standard neurological tests designed to assess the function of multiple cognitive and motor domains in HIV-infected subjects. We found that sphingomyelin:ceramide ratios for acyl chain lengths of C16∶0, C18∶0, C22∶0, and C24∶0 were associated with worse performance on several indices of memory. The most striking finding was for the acyl chain of C18∶0 that consistently associatedwith performance onmultiple tests of memory. These findings suggest that the sphingomyelin:ceramide ratio for C18∶0 may be a reasonable surrogate marker for memory dysfunction in HIV-infected subjects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Aittoniemi J, Niemela PS, Hyvonen MT, Karttunen M, Vattulainen I (2007). Insight into the putative specific interactions between cholesterol, sphingomyelin, and palmitoyl-oleoyl phosphatidylcholine.Biophys J 92: 1125–1137.

    Article  CAS  PubMed  Google Scholar 

  • Albert SM, Flater SR, Clouse R, Todak G, Stern Y, Marder K (2003). Medication management skill in HIV: I. Evidence for adaptation of medication management strategies in people with cognitive impairment. II. Evidence for a pervasive lay model of medication efficacy.AIDS Behav 7:329–3388.

    Article  PubMed  Google Scholar 

  • Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007). Updated research nosology for HIV-associated neurocognitive disorders.Neurology 69: 1789–1799.

    Article  CAS  PubMed  Google Scholar 

  • Bandaru VV, McArthur JC, Sacktor N, Cutler RG, Knapp EL, Mattson MP, Haughey NJ (2007). Associative and predictive biomarkers of dementia in HIV-1-infected patients.Neurology 68: 1481–1487.

    Article  CAS  PubMed  Google Scholar 

  • Bandaru VV, Troncoso J, Wheeler D, Pletnikova O, Wang J, Conant K, Haughey NJ (2009). ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer’s but not normal brain.Neurobiol Aging 30: 591–599.

    Article  CAS  PubMed  Google Scholar 

  • Benton AL (1951).The Visual Retention Test.New York: Psychological Corporation.

    Google Scholar 

  • Boisse L, Gill MJ, Power C (2008). HIV infection of the central nervous system: clinical features and neuropathogenesis.Neurol Clin 26: 799–819, x.

    Article  PubMed  Google Scholar 

  • Cardenas V, Meyerhoff D, Studholme C, Kornak J, Rothlind J, Lampiris H, Neuhaus J, Grant R, Chao L, Truran D, Weiner M (2009). Evidence for ongoing brain injury in human immunodeficiency virus-positive patients treated with antiretroviral therapy.J NeuroVirol 15: 1–10.

    Article  Google Scholar 

  • Clement AB, Gamerdinger M, Tamboli IY, Lutjohann D, Walter J, Greeve I, Gimpl G, Behl C (2009). Adaptation of neuronal cells to chronic oxidative stress is associated with altered cholesterol and sphingolipid homeostasis and lysosomal function.J Neurochem 111: 669–682.

    Article  CAS  PubMed  Google Scholar 

  • Concha M, Selnes OA, McArthur J, Nance-Sproson T, Updike ML, Royal W, Solomon L, Vlahov D (1995). Normative data for a brief neuropsychological test battery in a cohort of injecting drug users.Int J Addict 30: 832–841.

    Google Scholar 

  • Cutler RG, Haughey NJ, Tammara A, McArthur JC, Nath A, Reid R, Vargas DL, Pardo CA, Mattson MP (2004a). Dysregulation of sphingolipid and sterol metabolism by ApoE4 in HIV dementia.Neurology 63: 626–630.

    CAS  PubMed  Google Scholar 

  • Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K, Troncoso JC, Mattson MP (2004b). Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer’s disease.Proc Natl Acad Sci USA 101: 2070–2075.

    Article  CAS  PubMed  Google Scholar 

  • Cutler RG, Pedersen WA, Camandola S, Rothstein JD, Mattson MP (2002). Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis.Ann Neurol 52: 448–457.

    Article  CAS  PubMed  Google Scholar 

  • Dunbar N, Brew B (1997). Neuropsychological dysfunction in HIV infection: a review.J Neuro AIDS 1: 73–102.

    Article  CAS  Google Scholar 

  • Flowers KA, Robertson C (1985). The effects of Parkinson’s disease on the ability to maintain a mental set.J Neurol Neurosurg Neuropsychiatry 48: 517–529.

    Article  CAS  Google Scholar 

  • Gallegos CE, Pediconi MF, Barrantes FJ (2008). Ceramides modulate cell-surface acetylcholine receptor levels.Biochim Biophys Acta 1778: 917–930.

    Article  CAS  PubMed  Google Scholar 

  • Galvan C, Camoletto PG, Dotti CG, Aguzzi A, Ledesma MD (2005). Proper axonal distribution of PrP(C) depends on cholesterol-sphingomyelin-enriched membrane domains and is developmentally regulated in hippocampal neurons.Mol Cell Neurosci 30: 304–315.

    Article  CAS  PubMed  Google Scholar 

  • Gelman BB, Soukup VM, Holzer CE, 3rd, Fabian RH, Schuenke KW, Keherly MJ, Richey FJ, Lahart CJ (2005). Potential role for white matter lysosome expansion in HIV-associated dementia.J Acquir Immune Defic Syndr 39: 422–425.

    Article  CAS  PubMed  Google Scholar 

  • Gongvatana A, Schweinsburg BC, Taylor MJ, Theilmann RJ, Letendre SL, Alhassoon OM, Jacobus J, Woods SP, Jernigan TL, Ellis RJ, Frank LR, Grant I (2009). White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals.J NeuroVirol 15: 187–195.

    Article  PubMed  Google Scholar 

  • Haughey NJ (2010). Sphingolipids in neurodegeneration.Neuromol Med Accessed: Aug 25 2010. [Epub ahead of print].

  • Haughey NJ, Cutler RG, Tamara A, McArthur JC, Vargas DL, Pardo CA, Turchan J, Nath A, Mattson MP (2004). Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia.Ann Neurol 55: 257–267.

    Article  CAS  PubMed  Google Scholar 

  • He X, Huang Y, Li B, Gong CX, Schuchman EH (2008). Deregulation of sphingolipid metabolism in Alzheimer’s disease.Neurobiol Aging 31: 398–408.

    Article  PubMed  Google Scholar 

  • Huitema K, van den Dikkenberg J, Brouwers JF, Holthuis JC (2004). Identification of a family of animal sphingomyelin synthases.EMBO J 23: 33–44.

    Article  CAS  PubMed  Google Scholar 

  • Kaiser HJ, Lingwood D, Levental I, Sampaio JL, Kalvodova L, Rajendran L, Simons K (2009). Order of lipid phases in model and plasma membranes.Proc Natl Acad Sci U S A 106: 16645–16650.

    Article  CAS  PubMed  Google Scholar 

  • Klove H (1963). Clinical neuropsychology.Med Clin North Am 47: 1647–1658.

    CAS  PubMed  Google Scholar 

  • Mao C, Obeid LM (2008). Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate.Biochim Biophys Acta 1781: 424–434.

    CAS  PubMed  Google Scholar 

  • Marchesini N, Hannun YA (2004). Acid and neutral sphingomyelinases: roles and mechanisms of regulation.Biochem Cell Biol 82: 27–44.

    Article  CAS  PubMed  Google Scholar 

  • Marder K, Albert SM, McDermott MP, McArthur JC, Schifitto G, Selnes OA, Sacktor N, Stern Y, Palumbo D, Kieburtz K, Cohen B, Orme C, Epstein LG (2003). Inter-rater reliability of a clinical staging of HIV-associated cognitive impairment.Neurology 60: 1467–1473.

    CAS  PubMed  Google Scholar 

  • McMurtray A, Nakamoto B, Shikuma C, Valcour V (2008). Cortical atrophy and white matter hyperintensities in HIV: the Hawaii Aging with HIV Cohort Study.J Stroke Cerebrovasc Dis 17: 212–217.

    Article  PubMed  Google Scholar 

  • Meer GV, Hoetzl S (2009). Sphingolipid topology and the dynamic organization and function of membrane proteins.FEBS Lett 584: 1800–1805.

    Article  PubMed  Google Scholar 

  • Miller EN, Satz P, Visscher B (1991). Computerized and conventional neuropsychological assessment of HIV-1-infected homosexual men.Neurology 41: 1608–1616.

    CAS  PubMed  Google Scholar 

  • Mizutani Y, Kihara A, Igarashi Y (2006). LASS3 (longevity assurance homologue 3) is a mainly testis-specific (dihydro) ceramide synthase with relatively broad substrate specificity.Biochem J 398: 531–538.

    Article  CAS  PubMed  Google Scholar 

  • Nath A, Schiess N, Venkatesan A, Rumbaugh J, Sacktor N, McArthur J (2008). Evolution of HIV dementia with HIV infection.Int Rev Psychiatry 20: 25–31.

    Article  PubMed  Google Scholar 

  • Niemela PS, Hyvonen MT, Vattulainen I (2006). Influence of chain length and unsaturation on sphingomyelin bilayers.Biophys J 90: 851–863.

    Article  CAS  PubMed  Google Scholar 

  • Nygren H, Borner K, Hagenhoff B, Malmberg P, Mansson JE (2005). Localization of cholesterol, phosphocholine and galactosylceramide in rat cerebellar cortex with imaging TOF-SIMS equipped with a bismuth cluster ion source.Biochim Biophys Acta 1737: 102–110.

    CAS  PubMed  Google Scholar 

  • Pewzner-Jung Y, Ben-Dor S, Futerman AH (2006). When do Lasses (longevity assurance genes) become CerS (ceramide synthases)?: Insights into the regulation of ceramide synthesis.J Biol Chem 281: 25001–25005.

    Article  CAS  PubMed  Google Scholar 

  • Quinn PJ, Wolf C (2009). Thermotropic and structural evaluation of the interaction of natural sphingomyelins with cholesterol.Biochim Biophys Acta 1788: 1877–1889.

    Article  CAS  PubMed  Google Scholar 

  • Rey A (1941). L’examen psychological dans les cas d’encephalopathie traumatique.Arch Psychol 28: 286–340.

    Google Scholar 

  • Roc AC, Ances BM, Chawla S, Korczykowski M, Wolf RL, Kolson DL, Detre JA, Poptani H (2007). Detection of human immunodeficiency virus induced inflammation and oxidative stress in lenticular nuclei with magnetic resonance spectroscopy despite antiretroviral therapy.Arch Neurol 64: 1249–1257.

    Article  PubMed  Google Scholar 

  • Selnes OA, Jacobson L, Machado AM, Becker JT, Wesch J, Miller EN, Visscher B, McArthur JC (1991). Normative data for a brief neuropsychological screening battery. Multicenter AIDS Cohort Study.Percept Mot Skills 73: 539–550.

    Article  CAS  PubMed  Google Scholar 

  • Takeuchi J, Okada M, Toh-e A, Kikuchi Y (1995). The SMS1 gene encoding a serine-rich transmembrane protein suppresses the temperature sensitivity of the htr1 disruptant in Saccharomyces cerevisiae.Biochim Biophys Acta 1260: 94–96.

    PubMed  Google Scholar 

  • Tozzi V, Balestra P, Bellagamba R, Corpolongo A, Salvatori MF, Visco-Comandini U, Vlassi C, Giulianelli M, Galgani S, Antinori A, Narciso P (2007). Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors.J Acquir Immune Defic Syndr 45: 174–182.

    Article  PubMed  Google Scholar 

  • Valcour V, Watters MR, Williams AE, Sacktor N, McMurtray A, Shikuma C (2008). Aging exacerbates extrapyramidal motor signs in the era of highly active antiretroviral therapy.J NeuroVirol 14: 362–367.

    Article  CAS  PubMed  Google Scholar 

  • Wechsler D (1981).Wechsler Adult Intelligence Scale— Revised.New York:Psychological Corporation.

    Google Scholar 

  • Wheeler D, Bandaru VV, Calabresi PA, Nath A, Haughey NJ (2008). A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis.Brain 131: 3092–3102.

    Article  PubMed  Google Scholar 

  • Wheeler D, Knapp E, Bandaru VV, Wang Y, Knorr D, Poirier C, Mattson MP, Geiger JD, Haughey NJ (2009). Tumor necrosis factor-alpha-induced neutral sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors.J Neurochem 109: 1237–1249.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Norman J Haughey.

Additional information

This paper was first published online on Early Online on 18 November 2010.

Michelle M. Mielke and Veera Venkata Ratnam Bandaru contributed equally to this work.

The sterlingefforts of the research subjects who provided time and samples are appreciated.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mielke, M.M., Bandaru, V.V.R., McArthur, J.C. et al. Disturbance in cerebral spinal fluid sphingolipid content is associated with memory impairment in subjects infected with the human immunodeficiency virus. Journal of NeuroVirology 16, 445–456 (2010). https://doi.org/10.1007/BF03210850

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03210850

Keywords

Navigation